Capturing Unicorns: Targeting Cancers With TP53 Mutations, RAS Alterations Beyond G12C, and MTAP Loss—No Target Is Out of the Realm of Possibility Bispecific antibodies (bsAbs) have emerged as a novel ...

A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...

Immunoassays are methods for detecting and quantifying analytes within a biological sample based on specific antigen-antibody reaction. They have been widely used in scientific research and ...

An antigen is any substance that can trigger an immune response in the body. Antigens are typically proteins or polysaccharides that are recognized as foreign or potentially harmful by the immune ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

Scientists from the US have recently characterized a panel of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies to identify molecular features of public antibody responses ...

Systemic autoimmune diseases are characterized by inflammation of multiple organs and can have devastating consequences for patients. There is a dire need for treatments against these diseases. RNase ...

Antibody-drug conjugates (ADCs) have reshaped the cancer treatment landscape across a variety of different tumor types. ADCs' peculiar pharmacologic design combines the cytotoxic properties of ...

There are three different ways to test for COVID-19: PCR tests, antigen tests and antibody tests. Each method is best for a different stage of COVID-19 infection. Used in sequence, all three methods ...

Several types of antibody-mediated diseases are known. Some are thought to be adverse effects of vaccination, which is logical since vaccines, by definition, cause their effects via stimulation of the ...